World News
-
Fountain Healthcare Partners raises €118M for Third Fund
World | News | 0 Comment | 24 May, 2019
Fountain Healthcare Partners announces the initial closing of its third fund, Fountain Healthcare Partners Fund III, L.P. (“Fund III”) with €118 million of committed capita...Read more
-
Merck grants $1.99 M to ACS to improve cancer care
World | News | 0 Comment | 23 May, 2019
The Merck Foundation (the Foundation) and the American Cancer Society (ACS) announced that the Foundation awarded a $1.99 million, five-year grant to ACS to improve support and access to ca...Read more
-
Acutus Medical announces strategic acquisition & new partnerships in Monitoring and Therapy
World | News | 0 Comment | 22 May, 2019
Acutus Medical recently announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfoli...Read more
-
Novel technique reduces obstruction risk in heart valve replacement: NIH
World | News | 0 Comment | 22 May, 2019
Researchers at the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, have developed a novel technique that prevents the obstruction of blood flo...Read more
-
Merck to acquire Peloton Therapeutics in a $1.05B deal
World | News | 0 Comment | 23 May, 2019
Merck, known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. has announced that the companies have entered into a definitive agreement under which Merck, through...Read more
-
I Holland launches online training for pharmaceutical, nutraceutical professionals
World | News | 0 Comment | 21 May, 2019
The introduction of technology enabled learning is helping companies improve the skills of their staff and is seeing huge growth in recent years. This increase is being seen through al...Read more
-
Merck joins TRANSVAC2 programme to advance vaccine development
World | News | 0 Comment | 21 May, 2019
Merck, a leading science and technology company, has announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative...Read more
-
Parvus Therapeutics, Genetech collaborate for autoimmune diseases
World | News | 0 Comment | 20 May, 2019
Parvus Therapeutics, a biopharmaceutical company focused on the development of disease-specific immunoregulatory medicines to treat autoimmune diseases without impairing normal immunity, ha...Read more
-
World | News | 0 Comment | 20 May, 2019
GladiaTOX, a new open-source solution for the analysis of high content screening (HCS) data in biomedical research, has been released on the online Bioconductor platform. Written in the R p...Read more
-
Thermo Fisher to acquire GSK API Site for €90 M
World | News | 0 Comment | 20 May, 2019
Thermo Fisher Scientific Inc. the world leader in serving science, has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSm...Read more
-
Lonza, Synpromics enter Biomanufacturing Partnership
World | News | 0 Comment | 17 May, 2019
Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manuf...Read more
-
Inovio, Qiagen enter into a precision medicine partnership
World | News | 0 Comment | 17 May, 2019
Inovio Pharmaceuticals and QIAGEN have announced a collaboration to co-develop a diagnostic test to identify patients most likely to respond to VGX-3100, Inovio's immunotherapy to trea...Read more
-
SpinalCyte launches initiative to highlight advances in Fibroblast Technology
World | News | 0 Comment | 17 May, 2019
SpinalCyte, LLC, a clinical-stage regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs) has announced a new comprehensive resource to ra...Read more
-
DNA Script raises $38.5 M in Series B financing
World | News | 0 Comment | 16 May, 2019
DNA Script has announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe’s largest and most experienced healthcare investment firms. Bpifrance, th...Read more
-
J & J outlines strategy to deliver Above-Market Growth
World | News | 0 Comment | 16 May, 2019
Johnson & Johnson will host a meeting with industry analysts to review the strategy of its Janssen Pharmaceutical Companies to deliver above-market, compound annual growth through 2023....Read more
-
FDA approves EYLEA injection for diabetic retinopathy
World | News | 0 Comment | 15 May, 2019
Regeneron Pharmaceuticals has announced that USFDA has approved EYLEA® (aflibercept) Injection to treat all stages of diabetic retinopathy (DR), and thereby reduce the risk of blin...Read more
-
Pfizer acquires clinical stage biotech Therachon
World | News | 0 Comment | 15 May, 2019
Pfizer has recently entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare diseases, wi...Read more
-
Merck-Pfizer’s combination drug gets FDA nod to treat RCC
World | News | 0 Comment | 15 May, 2019
Merck and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved BAVENCIO® (avelumab) in combination with axitinib(Inlyta) for the first-line treatm...Read more
